Long‐acting muscarinic antagonists (LAMA) added to inhaled corticosteroids (ICS) versus the same dose of ICS alone for adults with asthma
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Long‐acting Muscarinic Antagonists (LAMA) Added to Inhaled Corticosteroids (ICS) Versus the Same Dose of ICS Alone for Adults With Asthma." Cochrane Abstracts, Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/435564/all/Medical_treatment_for_botulism:_Cochrane_systematic_review. Accessed 19 March 2024.
Long‐acting muscarinic antagonists (LAMA) added to inhaled corticosteroids (ICS) versus the same dose of ICS alone for adults with asthma. Cochrane Abstracts. https://evidence.unboundmedicine.com/evidence/view/Cochrane/435564/all/Medical_treatment_for_botulism:_Cochrane_systematic_review. Accessed March 19, 2024.
Long‐acting muscarinic antagonists (LAMA) added to inhaled corticosteroids (ICS) versus the same dose of ICS alone for adults with asthma. In Cochrane Abstracts https://evidence.unboundmedicine.com/evidence/view/Cochrane/435564/all/Medical_treatment_for_botulism:_Cochrane_systematic_review
Long‐acting Muscarinic Antagonists (LAMA) Added to Inhaled Corticosteroids (ICS) Versus the Same Dose of ICS Alone for Adults With Asthma [Internet]. In: Cochrane Abstracts. [cited 2024 March 19]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/435564/all/Medical_treatment_for_botulism:_Cochrane_systematic_review.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Long‐acting muscarinic antagonists (LAMA) added to inhaled corticosteroids (ICS) versus the same dose of ICS alone for adults with asthma
ID - 435564
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/435564/all/Medical_treatment_for_botulism:_Cochrane_systematic_review
DB - Evidence Central
DP - Unbound Medicine
ER -